Nautilus Biotechnology, Inc.
NAUT
$1.70
-$0.15-8.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.98M | 29.63M | 31.00M | 31.38M | 31.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.02M | 78.71M | 81.48M | 81.50M | 81.47M |
| Operating Income | -75.02M | -78.71M | -81.48M | -81.50M | -81.47M |
| Income Before Tax | -65.69M | -68.66M | -70.78M | -70.21M | -69.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.69 | -68.66 | -70.78 | -70.21 | -69.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.69M | -68.66M | -70.78M | -70.21M | -69.64M |
| EBIT | -75.02M | -78.71M | -81.48M | -81.50M | -81.47M |
| EBITDA | -73.15M | -76.79M | -79.50M | -79.40M | -79.42M |
| EPS Basic | -0.52 | -0.55 | -0.56 | -0.56 | -0.56 |
| Normalized Basic EPS | -0.34 | -0.36 | -0.37 | -0.36 | -0.36 |
| EPS Diluted | -0.52 | -0.55 | -0.56 | -0.56 | -0.56 |
| Normalized Diluted EPS | -0.34 | -0.36 | -0.37 | -0.36 | -0.36 |
| Average Basic Shares Outstanding | 503.60M | 502.71M | 501.70M | 500.89M | 500.37M |
| Average Diluted Shares Outstanding | 503.60M | 502.71M | 501.70M | 500.89M | 500.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |